Accueil   Diary - News   All news One step more for NH TherAguix : Fund raising of 597 k€

One step more for NH TherAguix : Fund raising of 597 k€

NH TherAguix is happy to announce the close of its first fund raising campaign.

 

 

597k€ were obtained thanks to the support of a various range of investors including societies such as INSAVALOR, EZUS, AVNIR, Nano-H, Chematech and few individuals.

 

This capital raise is a major financial progress and it will help to create added value to the one already existing after one year of existence. Especially, NH TherAguix will be able to reinforce its clinical strategy by pursuing the development of its drug candidate AGuIX®, including preparation of phase 2 clinical trials, broadening of indications and production of other batches of drug. We look forward to deploying these funds successfully.

 

 

NH

 

 

To all the investors, your support means so much for all of us. On behalf of the team, I wish to warmly thank you all for your continued confidence during the raising process.

 

 

 

Logo

 

 

 

By continuing your navigation on our site, you accept the use of cookies and the collection of your data and personal information by Lyonbiopôle, for the purposes of measuring the traffic on the website, to provide statistics and to offer you adapted content to your centers of interest. To exercise your rights of access, rectification, opposition, deletion and portability, in accordance with the General Data Protection Regulation (EU 2016/679), you are informed that you can send your request to dpo@lyonbiopole.com. More details are available by clicking here I agree